va glp 1 study NEW #HRS2025 SCIENCE: The #TRANSFORMAF found that patients with #AFib and obesity treated with GLP-1 receptor agonists experienced fewer AF-related events. Key Takeaways: 1️⃣ 2,510 patients across 170 hospitals nationwide VA Study: Ozempic, Other GLP-1
Description
The baseline BMI value decreased by income level ($3550K: 38.0, p = 0.6
Choose FuturHealth if You like the idea of meal deliveries and lifestyle coaching
Structure Therapeutics GSBR-1290 and Vikings VK2735 are advancing differentiated mechanisms, while Roche and other players explore next-generation oral obesity medications
Short-acting GLP-1 RAs Long-acting GLP-1 RAs Short-acting
Detailed records support timely changes in diet, exercise, and dosing to prevent small issues from becoming setbacks
Metabolic health impacts cognitive performance
